Survivin is an important oncogene and its expression is directly associated with enhanced proliferation, resistance to chemotherapy [58], [59], reduced apoptosis [60], enhanced angiogenesis [61], poor outcome [58], [62] and increased rate of tumor recurrence [63]. The gene discussed is BIRC5; the disease is neoplasm.